OPRX Free Cash Flow
$18.36MTTM · USD
Period ending:
OPRX FY Free Cash FlowUSD
$18.66M-$8.11M
2007-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
OPRX free cash flow history
Operating cash flow minus capital expenditures. The available annual fiscal periods series contains 19 observations from Dec 31, 2007 to Dec 31, 2025.
| Period ending | Free Cash Flow (USD) |
|---|---|
| 18,657,000 | |
| 4,777,000 | |
| -8,111,000 | |
| 10,409,513 | |
| 240,040 | |
| -6,435,111 | |
| -3,248,513 | |
| 701,542 | |
| -1,522,074 | |
| -815,503 | |
| 414,146 | |
| -466,302 | |
| 833,980 | |
| -674,903 | |
| -756,379 | |
| -1,537,050 | |
| -1,877,262 | |
| -930,023 | |
| -429,214 |
Compare free cash flow
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) free cash flow
- Bridgebio Pharma Inc (BBIO) free cash flow
- Brightspring Health Services Inc (BTSG) free cash flow
- Madrigal Pharmaceuticals Inc (MDGL) free cash flow
- Ensign Group Inc (ENSG) free cash flow
- Glaukos Corp (GKOS) free cash flow
- Vaxcyte Inc (PCVX) free cash flow
- Krystal Biotech Inc (KRYS) free cash flow
All OPRX financial metrics · OPRX stock overview · How to interpret financial metrics
